| Dr Beverley Faye James, MD | |
|
9101 W 73rd St Apt 206, Overland Park, KS 66204-1685 | |
| (913) 262-6161 | |
| Not Available |
| Full Name | Dr Beverley Faye James |
|---|---|
| Gender | Female |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 9101 W 73rd St Apt 206, Overland Park, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043379522 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 04-16557 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Beverley Faye James, MD 9101 W 73rd St Apt 206, Overland Park, KS 66204-1685 Ph: (913) 262-6161 | Dr Beverley Faye James, MD 9101 W 73rd St Apt 206, Overland Park, KS 66204-1685 Ph: (913) 262-6161 |
News Archive
The Eighth Circuit Court of Appeals heard arguments Thursday regarding whether a health law legal challenge brought by two Missouri residents should be revived.
Amgen, the largest standalone biotechnology company, and generic drug firm Watson Pharmaceuticals will collaborate on developing biosimilar drugs for cancer.
The Breast Cancer Survivor Coalition for Advancement, Reform and Equity (Because we Care) today praised a House of Representatives committee for adopting an amendment to the "America's Affordable Health Choices Act" (H.R. 3200) that would remove barriers to care for breast cancer survivors.
Welichem today announced that the Company has begun to enroll patients in a Phase IIb clinical trial with its lead candidate, WBI-1001. The Phase IIb clinical trial is a double-blinded, placebo-controlled, 12-week-treatment study.
UPMC has implanted the first patient in the United States with a new wireless retinal device as part of a clinical trial aimed at restoring partial sight to patients with advanced age-related macular degeneration, a disease that leads to permanent blindness.
› Verified 2 days ago
Anne S. Clark, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 10500 Barkley St Ste 220, Overland Park, KS 66212 Phone: 913-738-9235 Fax: 913-738-9285 | |
Stacy Dawn Younger, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 12140 Nall Ave, Suite 230, Overland Park, KS 66209 Phone: 913-661-9434 Fax: 913-661-4688 | |
Muhammad Mahdi Nashatizadeh, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 10550 Quivira Rd, Suite 530, Overland Park, KS 66215 Phone: 913-599-3828 Fax: 913-599-3451 | |
Ian Leslie Belson, DO Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 12140 Nall, Suite 230, Overland Park, KS 66209 Phone: 913-661-9434 Fax: 913-661-4688 | |
Dr. Bernard Mark Abrams, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 5520 College Boulevard, Suite 320, Overland Park, KS 66211 Phone: 816-322-4834 Fax: 816-322-2005 | |
Dr. Joan Mollman, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 5347 W 100th Ter, Overland Park, KS 66207 Phone: 610-864-8338 |